Serum cystatin C in patients with head and neck carcinoma

Clinica Chimica Acta

Volumn 344, Issue 1-2, 2004, Pages 155-161

  Strojan, Primož ^a   Svetic, Branka ^a   Šmid, Lojze ^b   Kos, Janko ^c,d  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d KRKA D D   (Slovenia)

Author keywords

Cystatin C; Head and neck carcinoma; Tumor marker

Indexed keywords

CYSTATIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HEMOCONCENTRATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LARYNX CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELAPSE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; CYSTATINS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 2442486843     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.02.011     Document Type: Article

References (31)

1. Vokes E.E., Weichselbaum R.R., Lippman S.M., Hong W.K. Head and neck cancer. N. Engl. J. Med. 328:1993;184-194
2. Lal H. Biochemical studies in head and neck cancers. Clin. Biochem. 27:1994;235-295
3. Quon H., Liu F.F., Cummings B.J. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck. 23:2001;147-159
4. Kos J., Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol. Rep. 5:1998;1349-1361
5. Abrahamson M., Grubb A., Olafsson I., Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 216:1987;229-233
6. Abrahamson M., Barrett A.J., Salvesen G., Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 261:1986;11282-11289
7. Jacobsson B., Lignelid H., Bergerheim U.S.R. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology. 26:1995;559-564
8. Buttle D.J., Burnett D., Abrahamson M. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. Scand. J. Clin. Lab. Invest. 50:1990;509-516
9. Cimerman N., Meško Brguljan P., Krašovec M., Šuškovic̀ S., Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin. Chim. Acta. 300:2000;83-95
10. Nagai A., Murakawa Y., Terashima M., et al. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology. 55:2000;1828-1832
11. Takeuchi M., Fukuda Y., Nakano I., Katano Y., Hayakawa T. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Gastroenterol. Hepatol. 13:2001;951-955
12. Colle A., Tavera C., Prevot D., et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection: a new avidin-biotin ELISA assay for its measurement. J. Immunoassay. 13:1992;47-60
13. Kabanda A., Jadoul M., Pochet J.M., Lauwerys R., de Strihou C.V., Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int. 45:1994;1689-1696
14. Shimode K., Fujihara S., Nakamura M., Kobayashi S., Tsunematsu T. Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid. Stroke. 22:1991;860-866
15. Brzin J., Popovic̀ T., Turk V., Borchart U., Machleidt W. Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem. Biophys. Res. Commun. 118:1984;103-109
16. Nagai A., Terashima M., Harada T., et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin. Chim. Acta. 329:2003;53-60
17. Kos J., Štabuc B., Schweiger A., et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3:1997;1815-1822
18. Kos J., Krašovec N., Cimerman N., Nielsen H.J., Christensen I.J., Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 6:2000;505-511
19. Sobin L.H., Wittekind Ch. International Union Against Cancer (UICC): TNM classification of malignant tumours. fifth ed. 1997;20-37 Wiley-Liss, New York
20. Azzopardi J.G., Chepizk O.F., Hartman W.H. International histological classification of tumours no. 2: histological typing of breast tumours. second ed. 1981;World Health Organization, Geneva
21. Cimerman N., Trstenjak Prebanda M., Turk B., Popovic̀ T., Dolenc I., Turk V. Interaction of cystatin C variants with papain and human cathepsins B, H and L. J. Enzym. Inhib. 14:1999;167-174
22. Kos J., Werle B., Lah T., Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int. J. Biol. Markers. 15:2000;84-89
23. Štabuc B., Vrhovec L., Štabuc-Šilih M., Cizej T.E. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin. Chem. 46:2000;193-197
24. Newman D.J., Thakkar H., Edwards R.G., et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 47:1995;312-318
25. Finney H., Williams A.H., Price C.P. Serum cystatin C in patients with myeloma. Clin. Chim. Acta. 309:2001;1-6
26. 2-microglobulin/cystatin C ratio - a potential marker of post-transplant lymphoproliferative disease. Clin. Nephrol. 58:2001;417-422
27. Strojan P., Budihna M., Šmid L., et al. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 6:2000;1052-1062
28. Cooper J.S., Fu K., Marks J., Silverman S. Late effects of radiation-therapy in the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1141-1164
29. Poteryaeva O.N., Falameeva O.V., Zhanaeva S.Y., Svechnikova I.G., Korolenko T.A., Kaledin V.I. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma. Bull. Exp. Biol. Med. 1:2001;675-677
30. Cimerman N., Meško Brguljan P., Krašovec M., Šuškovic̀ S., Kos J. Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. Clin. Chim. Acta. 291:2000;89-95
31. Zore I., Krašovec M., Cimerman N., et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol. Chem. 382:2001;805-810